NIOX GROUP PLC
(the "Company" or the "Group")
Result of General Meeting
Oxford, UK - 16 October 2024: NIOX Group plc (AIM: NIOX), a company engaged in the design, development and commercialisation of medical devices for asthma diagnosis and management, is pleased to announce that at the General Meeting of the Company held earlier today, the Tender Offer Resolution, as set out in the Notice of the General Meeting, was duly passed on a poll of votes. The number of total votes received from Shareholders by the Company were cast as follows:
| Resolution | For | % | Against | % | Withheld |
| Tender Offer Resolution | 276,380,521 | 99.73 | 3,829 | 0.00 | 47,823 |
Note: A vote "Withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "For" and "Against" shown.
The results of the Tender Offer will be announced on 17 October 2024.
Capitalised terms in this announcement (unless otherwise defined) have the same meanings as set out in the Circular.
| Contacts: | |
|
NIOX Group plc Ian Johnson, Executive Chairman Michael Roller, Chief Financial Officer
|
+44 (0) 3303 309 356
|
| Singer Capital Markets (Nominated Adviser and Joint Broker) Jen Boorer / James Fischer / James Todd
| +44 (0) 20 7496 3000 |
| | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.